Frequency of inherited variants in the MEFV gene in myelodysplastic syndrome and acute myeloid leukemia

被引:9
|
作者
Celik, Serkan [2 ]
Oktenli, Cagatay [1 ]
Kilicaslan, Emrah [2 ]
Tangi, Fatih [2 ]
Sayan, Ozkan [3 ]
Ozari, H. Onur [2 ]
Ipcioglu, Osman [4 ]
Sanisoglu, Yavuz S. [5 ]
Terekeci, M. Hakan [2 ]
Erikci, Alev A. [3 ]
机构
[1] Anadolu Med Ctr, Dept Internal Med & Geriatr, TR-41400 Kocaeli, Turkey
[2] GATA Haydarpasa Training Hosp, Div Internal Med, Istanbul, Turkey
[3] GATA Haydarpasa Training Hosp, Div Hematol, Istanbul, Turkey
[4] GATA Haydarpasa Training Hosp, Dept Biochem, Istanbul, Turkey
[5] Yildirim Beyazit Univ, Dept Biostat, Ankara, Turkey
关键词
MEFV gene; Acute myeloid leukemia; Myelodysplastic syndrome; FAMILIAL MEDITERRANEAN FEVER; NF-KAPPA-B; ACUTE MYELOGENOUS LEUKEMIA; TRANSCRIPTION FACTOR; PYRIN; MUTATIONS; ACTIVATION; APOPTOSIS; PROTEIN; CELLS;
D O I
10.1007/s12185-012-1022-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the frequency of inherited variants in the MEFV gene, which is mutated in familial Mediterranean fever (FMF), in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Eight MEFV gene variants (M694I, M694V, M680I (G/C-A), V726A, R761H, E148Q and P369S) were analyzed in 33 MDS patients, 47 AML patients and 65 healthy controls; none had a history or family history compatible with FMF. We identified two homozygous (E148Q/E148Q), one compound heterozygous (M694V/E148Q) and five heterozygous inherited variants in the MEFV gene in AML patients. We also identified nine heterozygous variants in MDS patients, while we found 11 heterozygous variants in controls. The mean overall frequency of inherited variants in the MEFV gene rate was higher in MDS (chi(2) = 4.241; P = 0.039) and AML (chi(2) = 3.870; P = 0.043) patients than in healthy controls. In conclusion, this study reports high frequency of inherited variants in the MEFV gene in patients with MDS and AML. However, the hypothesis that MEFV is a cancer susceptibility gene at this point remains speculative. Additional evidence from future studies is needed to allow a more thorough evaluation of this hypothesis.
引用
收藏
页码:285 / 290
页数:6
相关论文
共 50 条
  • [41] Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia
    Ambinder, Alexander J.
    DeZern, Amy E.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
    Jiahao Chen
    Yun-Ruei Kao
    Daqian Sun
    Tihomira I. Todorova
    David Reynolds
    Swathi-Rao Narayanagari
    Cristina Montagna
    Britta Will
    Amit Verma
    Ulrich Steidl
    Nature Medicine, 2019, 25 : 103 - 110
  • [43] Genomic Profiling of Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Gu, Weiying
    Liu, Yan
    Guo, Yanting
    Shang, Limei
    Wei, Wei
    Chen, Huijuan
    Wang, Xiaoxuan
    Hu, Xiangjing
    Song, Chao
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S278 - S278
  • [44] Successful treatment of patients with acute myeloid leukemia and Myelodysplastic Syndrome by decitabine
    Bulbul, Hale
    Davulcu, Eren A.
    Atilla, Fatos D.
    Ulusoy, Yusuf
    Soyer, Nur
    Saydam, Guray
    KUWAIT MEDICAL JOURNAL, 2022, 54 (03): : 385 - 391
  • [45] Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies
    Akpan, Imo J.
    Osman, Afaf E. G.
    Drazer, Michael W.
    Godley, Lucy A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 426 - 434
  • [46] Decitabine: An effective and safe treatment for myelodysplastic syndrome and acute myeloid leukemia
    Feng, Xianqi
    Chen, Xiangyun
    Nie, Shumin
    Chang, Yanyan
    Meng, Fanjun
    Zhou, Jingjing
    Mao, Chunxia
    Li, Tianlan
    Yan, Xueshen
    Huang, Junxia
    Liu, Shanshan
    Gao, Yan
    Xiao, Shuxin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (07) : 1471 - 1476
  • [47] Abnormalities in Chromosomes 5 and 7 in Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Kendrick, Tulene S.
    Buic, Daria
    Fuller, Kathy A.
    Erber, Wendy N.
    ANNALS OF LABORATORY MEDICINE, 2025, 45 (02) : 133 - 145
  • [48] Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
    Chen, Jiahao
    Kao, Yun-Ruei
    Sun, Daqian
    Todorova, Tihomira I.
    Reynolds, David
    Narayanagari, Swathi-Rao
    Montagna, Cristina
    Will, Britta
    Verma, Amit
    Steidl, Ulrich
    NATURE MEDICINE, 2019, 25 (01) : 103 - +
  • [49] Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia
    Savage, Sharon A.
    Walsh, Michael F.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (04) : 657 - +
  • [50] Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome
    Lai, B
    Estey, E
    Shen, Y
    Despa, S
    Kantarjian, H
    Beran, M
    Maushori, T
    Quackenbuch, RC
    Keating, M
    Albitar, M
    CANCER, 2002, 94 (01) : 14 - 17